首站-论文投稿智能助手
典型文献
OShnscc:a novel user-friendly online survival analysis tool for head and neck squamous cell carcinoma based on RNA expression profiles and long-term survival information
文献摘要:
Head and neck squamous cell carcinoma (HNSCC), as the most common type (>90%) of head and neck cancer, includes various epithelial malignancies that arise in the nasal cavity, oral cavity, pharynx, and larynx. In 2020, approximately 878000 new cases and 444000 deaths linked to HNSCC occurred world-wide (Sung et al., 2021). Due to the associated fre-quent recurrence and metastasis, HNSCC patients have poor prognosis with a five-year survival rate of 40%–50%(Jou and Hess, 2017). Therefore, novel prognostic biomarkers need to be developed to identify high-risk HNSCC patients and improve their disease outcomes.
文献关键词:
作者姓名:
Guosen ZHANG;Qiang WANG;Xinlei QI;Huimin YANG;Xiaodong SU;Manman YANG;Chao JIANG;Yang AN;Hong ZHENG;Lu ZHANG;Wan ZHU;Jiancheng GUO;Xiangqian GUO
作者机构:
Department of Predictive Medicine,Institute of Biomedical Informatics,Cell Signal Transduction Laboratory,Bioinformatics Center,Henan Provincial Engineering Center for Tumor Molecular Medicine,School of Basic Medical Sciences,Henan University,Kaifeng 475004,China;School of Software,Henan University,Kaifeng 475004,China;Department of Anesthesia,Stanford University,Stanford,CA 94305,USA;Department of Molecular Pathology,the Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Precision Medicine Center,Academy of Medical Sciences,Zhengzhou University,Zhengzhou 450052,China;Henan Institute of Medical and Pharmaceutical Sciences,Zhengzhou University,Zhengzhou 450052,China
引用格式:
[1]Guosen ZHANG;Qiang WANG;Xinlei QI;Huimin YANG;Xiaodong SU;Manman YANG;Chao JIANG;Yang AN;Hong ZHENG;Lu ZHANG;Wan ZHU;Jiancheng GUO;Xiangqian GUO-.OShnscc:a novel user-friendly online survival analysis tool for head and neck squamous cell carcinoma based on RNA expression profiles and long-term survival information)[J].浙江大学学报(英文版)(B辑:生物医学和生物技术),2022(03):249-257
A类:
OShnscc,larynx,Sung,Jou
B类:
novel,user,friendly,online,survival,analysis,tool,head,neck,squamous,cell,carcinoma,expression,profiles,long,term,information,Head,HNSCC,most,common,type,cancer,includes,various,epithelial,malignancies,that,arise,nasal,cavity,oral,pharynx,In,approximately,new,cases,deaths,linked,occurred,world,wide,Due,associated,fre,quent,recurrence,metastasis,patients,have,poor,prognosis,five,year,rate,Hess,Therefore,prognostic,biomarkers,need,be,developed,identify,high,risk,improve,their,disease,outcomes
AB值:
0.648738
相似文献
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
Shen Junyi;Qi Weili;Dai Junlong;Leng Shusheng;Jiang Kangyi;Zhang Yu;Ran Shun;Li Chuan;Wen Tianfu-Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Laboratory of Liver Transplantation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Chengdu University, Chengdu, Sichuan 610072, China;Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Leshan, Leshan, Sichuan 614700, China;Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, Chinese Academy of Sciences, Chengdu, Sichuan 610072, China;Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou 550000, China
Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission
Zhang Yongzhan;Bai Lu;Cheng Yifei;Lu Aidong;Wang Yu;Wu Jun;Zhang Xiaohui;Zuo Yingxi;Xu Lanping;Jia Yueping;Huang Xiaojun;Zhang Leping-Department of Pediatrics, Peking University People’s Hospital, Peking University, Beijing 100044, China;Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China;Department of Pediatrics, Peking University Shougang Hospital, Peking University, Beijing 100144, China;Department of Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China
Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma
Bangrong Cao;Kun Mi;Wei Dai;Tong Liu;Tianpeng Xie;Qiang Li;Jinyi Lang;Yongtao Han;Lin Peng;Qifeng Wang-Radiation Oncology Key Laboratory of Sichuan Province Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Biobank Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Thoracic Surgery Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Medical Imaging Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Radiation Oncology,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China
Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray
Yangyang Sun;Chengxi Liu;Huidong Zhong;Chenguang Wang;Haibo Xu;Wei Chen-Shenzhen Key Laboratory of Synthetic Genomics,Guangdong Provincial Key Laboratory of Synthetic Genomics,CAS Key Laboratory of Quantitative Engineering Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen 518055,China;Department of Urology,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,International Cancer Center,Shenzhen University School of Medicine,Shenzhen 518039,China;State Key Laboratory of Chemical Biology and Drug Discovery,Food Safety and Technology Research Centre and Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong 999077,China;Department of Medicinal Chemistry,Shantou University Medical College,Shantou 515041,China
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways
Wan Li;Hongqing Cai;Liwen Ren;Yihui Yang;Hong Yang;Jinyi Liu;Sha Li;Yizhi Zhang;Xiangjin Zheng;Wei Tan;Guanhua Du;Jinhua Wang-The State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Beijing 100050,China;Key Laboratory of Drug Target Research and Drug Screen,Institute of Materia Medica,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100050,China;Department of Neurosurgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;State Key Laboratory of Molecular Oncology,Center for Cancer Precision Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;School of Pharmacy,Xinjiang Medical University,Urumqi 830011,China;Xinjiang Institute of Materia Medica,Urumqi 830004,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。